Bank Of America Corp Talis Biomedical Corp Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.45 - $11.67 $55 - $1,435	-123 Reduced 75.46%	40 $0
Q3 2022 Nov 14, 2022	BUY	$0.7 - $10.79 $1 - $21	2 Added 1.24%	163 $0
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $29,805 - $52,987	-36,797 Reduced 99.56%	161 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $14,384 - $46,362	-11,065 Reduced 23.04%	36,958 $52,000
Q4 2021 Feb 08, 2022	SELL	$3.81 - $6.17 $66,183 - $107,179	-17,371 Reduced 26.56%	48,023 $193,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $268,485 - $555,703	44,599 Added 214.47%	65,394 $409,000
Q2 2021 Sep 13, 2021	BUY	$9.62 - $14.56 $200,047 - $302,775	20,795 New	20,795 $230,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.6M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.